Drug information for ZYPREXA RELPREVV

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR EQ 210MG BASE/VIAL Prescription   OLANZAPINE PAMOATE olanzapine ELI LILLY CO 22173
2011-12-22 Other Important Information from FDA
2010-12-06 Letter
2010-12-04 Label
2010-07-27 Review
2010-07-27 Summary Review
2010-07-12 Letter
2010-06-11 Label
2010-06-03 Label
2010-06-03 Medication Guide
2010-06-02 Letter
2010-06-02 Letter
2010-05-07 Label
2010-05-03 Letter
2010-03-01 Other
2010-03-01 Medication Guide
2009-12-29 Letter
2009-12-15 Label
SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR EQ 300MG BASE/VIAL Prescription   OLANZAPINE PAMOATE olanzapine ELI LILLY CO   "
SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR EQ 405MG BASE/VIAL Prescription  (Reference Drug) OLANZAPINE PAMOATE olanzapine ELI LILLY CO   "

Drug Adverse Effects information for ZYPREXA RELPREVV

Role code Indications Reaction # Reports
PS AGITATION AGGRESSION 2
PS AGITATION AGITATION 2
PS AGITATION DRUG INEFFECTIVE 2
PS AGITATION HALLUCINATION, AUDITORY 2
PS CONSTIPATION AGGRESSION 3
PS CONSTIPATION AGITATION 3
PS CONSTIPATION DRUG INEFFECTIVE 3
PS CONSTIPATION HALLUCINATION, AUDITORY 3
PS DYSPEPSIA AGGRESSION 1
PS DYSPEPSIA AGITATION 1
PS DYSPEPSIA DRUG INEFFECTIVE 1
PS DYSPEPSIA HALLUCINATION, AUDITORY 1
PS HAEMORRHOIDS AGGRESSION 1
PS HAEMORRHOIDS AGITATION 1
PS HAEMORRHOIDS DRUG INEFFECTIVE 1
PS HAEMORRHOIDS HALLUCINATION, AUDITORY 1
PS PAIN AGGRESSION 1
PS PAIN AGITATION 1
PS PAIN DRUG INEFFECTIVE 1
PS PAIN HALLUCINATION, AUDITORY 1
PS PSYCHOTIC DISORDER AGGRESSION 2
PS PSYCHOTIC DISORDER AGITATION 2
PS PSYCHOTIC DISORDER DRUG INEFFECTIVE 2
PS PSYCHOTIC DISORDER HALLUCINATION, AUDITORY 2
PS SCHIZOAFFECTIVE DISORDER ABNORMAL BEHAVIOUR 1
PS SCHIZOAFFECTIVE DISORDER AGGRESSION 3
PS SCHIZOAFFECTIVE DISORDER CARDIAC ARREST 1
PS SCHIZOAFFECTIVE DISORDER DEATH 1
PS SCHIZOAFFECTIVE DISORDER DRUG INEFFECTIVE 1
PS SCHIZOAFFECTIVE DISORDER HOSPITALISATION 1
PS SCHIZOAFFECTIVE DISORDER SCHIZOPHRENIA 1
PS SCHIZOAFFECTIVE DISORDER TOXICITY TO VARIOUS AGENTS 1
PS SCHIZOPHRENIA AGITATION 2
PS SCHIZOPHRENIA AKATHISIA 1
PS SCHIZOPHRENIA DECREASED APPETITE 3
PS SCHIZOPHRENIA DISTURBANCE IN SOCIAL BEHAVIOUR 3
PS SCHIZOPHRENIA EOSINOPHIL COUNT INCREASED 1
PS SCHIZOPHRENIA FATIGUE 1
PS SCHIZOPHRENIA FEELING OF BODY TEMPERATURE CHANGE 1
PS SCHIZOPHRENIA HALLUCINATION, AUDITORY 3
PS SCHIZOPHRENIA HYPERSENSITIVITY 1
PS SCHIZOPHRENIA INJECTION SITE ERYTHEMA 1
PS SCHIZOPHRENIA INJECTION SITE HAEMORRHAGE 1
PS SCHIZOPHRENIA INJECTION SITE INDURATION 1
PS SCHIZOPHRENIA INJECTION SITE URTICARIA 1
PS SCHIZOPHRENIA LOSS OF CONSCIOUSNESS 1
PS SCHIZOPHRENIA MAJOR DEPRESSION 3
PS SCHIZOPHRENIA MUSCULAR WEAKNESS 1
PS SCHIZOPHRENIA OVERDOSE 3
PS SCHIZOPHRENIA PSYCHOTIC DISORDER 1
PS SCHIZOPHRENIA SCHIZOPHRENIA 1
PS SCHIZOPHRENIA SEDATION 1
PS SCHIZOPHRENIA WEIGHT DECREASED 3
PS SCHIZOPHRENIA WHITE BLOOD CELL COUNT DECREASED 1
PS SCHIZOPHRENIA, PARANOID TYPE HOSPITALISATION 1
PS SCHIZOPHRENIA, PARANOID TYPE OVERDOSE 2
PS SCHIZOPHRENIA, PARANOID TYPE SCHIZOPHRENIA 2
SS SCHIZOAFFECTIVE DISORDER CARDIAC ARREST 2
SS SCHIZOPHRENIA AKATHISIA 1
SS SCHIZOPHRENIA SCHIZOPHRENIA 1
Ads by Google